Help us: Donate
Follow us on:
×

Menu

Back

Tag: João Pedro de Magalhães

EARD2021 Joao Pedro de Magalhaes
In his talk at Ending Age-Related Diseases 2021, João Pedro de Magalhães discussed the difference between longevity and rejuvenation along with the need for more ambitious research. Script I think it's a very exciting time to be working on longevity. I prepared a slightly different presentation like I did two years ago when I was...
The Hallmarks of aging are the nine proposed reasons we age.
The hallmarks of aging, as presented in a 2013 paper [1], have been useful but do not provide a genuine explanatory paradigm, argue David Gems of University College London and João Pedro de Magalhães of the University of Liverpool in a pre-print paper [2]. They propose that biogerontology would benefit from replacing the hallmarks with...
Dr. João Pedro de Magalhães is a Professor at the University of Liverpool, England, where he studies aging and longevity at the genetic level, and he is also an affiliate Principal Investigator in the Neuroendocrinology and Aging Group at the University of Coimbra, Portugal. Dr. de Magalhães has built the Human Ageing Genomic Resources (HAGR),...
Pills
A bold feature article published in Drug Discovery Today illustrates the coming of age of longevity pharmacology. Dr. João Pedro de Magalhães, one of the biggest names in longevity research, outlined some of the great strides taken in the last two decades, as various discoveries have been made in the biology of aging. Lifespan has...
Journal Club Joao Pedro de Magalhaes
On Tuesday, June 30, the Journal Club returns, and our special guest Dr. João Pedro de Magalhães will be giving a talk and taking questions about the CellAge database. Dr. João Pedro de Magalhães and his team at the University of Liverpool recently published a new study in which they used a systems biology approach...
Few things in aging research are ever straightforward, and today's topic is no exception, as two researchers enjoy some back and forth regarding whether and how the World Health Organization (WHO) should recognize the aging processes as a disease. Proposing a new framework to facilitate development of rejuvenation therapies Back in November 2019, an international...